Roche announces grand opening of its Innovation Center Boston to drive advancements in Cardiovascular, Renal and Metabolic diseases

Positive

AI Analysis

Summary

Roche announced the grand opening of the Roche Genentech Innovation Center Boston to expand its US research presence in cardiovascular, renal, and metabolic disease research.

Importance:2/10

Sentiment:

0.30

infrastructureexpansionresearch facilitycardiovascularrenalmetabolic diseases

Related Companies

$RHHBY

Read the original article

Published by GlobeNewswire Pharma on September 17, 2026 6:30 PM

Read Original